Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres

Cell Growth and Differentiation

Volumn 12, Issue 11, 2001, Pages 525-534

  Goodwin, E C ^a   DiMaio, D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PROTEIN P105; PROTEIN P53; TELOMERASE;

ARTICLE; CARCINOMA CELL; CATALYSIS; CELL PROLIFERATION; ENZYME ACTIVITY; GENETIC MANIPULATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMERE LENGTH; SENESCENCE; TELOMERE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA;

CELL AGING; CELL DIVISION; CELL SIZE; DNA; DNA-BINDING PROTEINS; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HELA CELLS; HUMANS; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; RNA, MESSENGER; TELOMERASE; TELOMERE; TRANSDUCTION, GENETIC; VIRAL PROTEINS;

BOVINAE; BOVINE PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; PAPOVAVIRIDAE;

EID: 0035178727     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Can ends justify the means? Telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells
2. The two-stage mechanism controlling cellular senescence and immortalization
3. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
4. The biology of replicative senescence
5. INK4a
6. A role for both RB and p53 in the regulation of human cellular senescence
7. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of lifespan in human diploid fibroblasts
8. The role of senescence and immortalization in carcinogenesis
9. Senescence as a mode of tumor suppression
10. Cellular senescence as a tumor-protection mechanism: The essential role of counting
11. Replicative senescence: Implications for in vivo aging and tumor suppression
12. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
13. Telomere reduction in human colorectal carcinoma and with ageing
14. Telomeres shorten during ageing of human fibroblasts
15. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
16. Regulation of telomerase activity in immortal cell lines
17. Specific association of human telomerase activity with immortal cells and cancer
18. Telomere dynamics in an immortal human cell line
19. Evidence for a critical telomere length in senescence human fibroblasts
20. Telomere loss: Mitotic clock or genetic time bomb?
21. A theory of marginotomy
22. A reassessment of the telomere hypothesis of senescence
23. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
24. Human endothelial cell life extension by telomerase expression
25. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
26. Telomerase activity is sufficient to allow transformed cells to escape from crisis
27. Dissociation in in vitro telomerase activity, telomere maintenance, and cellular immortalization
28. Extension of life-span by introduction of telomerase into normal human cells
29. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
30. INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics
31. Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA
32. Inhibition of telomerase limits the growth of human cancer cells
33. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
34. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
35. Human papillomaviruses and cervical cancer
36. Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells
37. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
38. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteosome pathway
39. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between the transcription factor E2F and the retinoblastoma gene product
40. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
41. Association of human papillomavirus types 16 and 18 E6 proteins with p53
42. Telomerase activation by the E6 gene product of human papillomavirus type 16
43. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length
44. Inhibition of cervical carcinoma cell line proliferation by introduction of a bovine papillomavirus regulatory gene
45. 105 promoters
46. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region
47. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways
48. Activation of the endogenous p53 growth inhibitory pathway in HeLa cervical carcinoma cells by expression of the bovine papillomavirus E2 gene
49. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein
50. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression
51. Rapid induction of senescence in human cervical carcinoma cells
52. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells
53. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells
54. CIP-dependent pathways
55. Telomere length dynamics in telomerase-positive immortal human cell populations
56. Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase
57. Structure and variability of human chromosome ends
58. Telomere reduction in endometrial adenocarcinoma
59. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MPAK mitogenic signaling
60. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts
61. Senescence of human fibroblasts induced by oncogenic
62. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts
63. KIP1 in retino-blastoma protein-mediated senescence
64. p16INKa can initiate an autonomous senescence program
65. Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53
66. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
67. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
68. INK4A
69. CIP1 in spontaneously immortalized human fibroblasts
70. waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin
71. Reexpression of the retino-blastoma protein in tumor cells induces senescence and telomerase inhibition
72. Differentiation is inhibited and a senescence pathway is activated when Simian virus 40 tsA 58-transformed human retinoblasts are grown at the restrictive temperature
73. Progression of aging in human diploid cells transformed with a tsA mutant of simian virus 40
74. Growth of immortal simian virus 40 tsA-transformed human fibroblasts is temperature dependent
75. Transforming growth factor β triggers two independent-senescence programs in cancer cells
76. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents
77. Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres
78. Telomerase activity does not always imply telomere maintenance
79. Telomerase activation by human papillomavirus type 16 E6 protein: Induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites
80. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein